SI1594456T1 - Uporaba zmesi, ki vsebuje oksid vitamina k1 ali njegov derivat, pri zdravljenju in/ali preprečevanju dermatoloških lezij pri sesalcih - Google Patents

Uporaba zmesi, ki vsebuje oksid vitamina k1 ali njegov derivat, pri zdravljenju in/ali preprečevanju dermatoloških lezij pri sesalcih

Info

Publication number
SI1594456T1
SI1594456T1 SI200430948T SI200430948T SI1594456T1 SI 1594456 T1 SI1594456 T1 SI 1594456T1 SI 200430948 T SI200430948 T SI 200430948T SI 200430948 T SI200430948 T SI 200430948T SI 1594456 T1 SI1594456 T1 SI 1594456T1
Authority
SI
Slovenia
Prior art keywords
vitamin
derivative
oxide
composition
prevention
Prior art date
Application number
SI200430948T
Other languages
English (en)
Inventor
Alfred Marchal
Original Assignee
Auriga Internat S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03447019A external-priority patent/EP1442738A1/en
Application filed by Auriga Internat S A filed Critical Auriga Internat S A
Publication of SI1594456T1 publication Critical patent/SI1594456T1/sl

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Birds (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI200430948T 2003-01-20 2004-01-20 Uporaba zmesi, ki vsebuje oksid vitamina k1 ali njegov derivat, pri zdravljenju in/ali preprečevanju dermatoloških lezij pri sesalcih SI1594456T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31988703P 2003-01-20 2003-01-20
EP03447019A EP1442738A1 (en) 2003-01-28 2003-01-28 Dermatological cosmetic composition comprising vitamin K1 oxide
PCT/BE2004/000011 WO2004064798A1 (en) 2003-01-20 2004-01-20 Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions
EP04703319A EP1594456B1 (en) 2003-01-20 2004-01-20 Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions

Publications (1)

Publication Number Publication Date
SI1594456T1 true SI1594456T1 (sl) 2009-02-28

Family

ID=32773677

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430948T SI1594456T1 (sl) 2003-01-20 2004-01-20 Uporaba zmesi, ki vsebuje oksid vitamina k1 ali njegov derivat, pri zdravljenju in/ali preprečevanju dermatoloških lezij pri sesalcih

Country Status (14)

Country Link
US (1) US7939568B2 (sl)
EP (1) EP1594456B1 (sl)
JP (1) JP2006515873A (sl)
KR (1) KR20050103906A (sl)
CN (1) CN100531727C (sl)
AT (1) ATE406868T1 (sl)
CA (1) CA2513324C (sl)
DE (1) DE602004016292D1 (sl)
DK (1) DK1594456T3 (sl)
ES (1) ES2314365T3 (sl)
HK (1) HK1087010A1 (sl)
PT (1) PT1594456E (sl)
SI (1) SI1594456T1 (sl)
WO (1) WO2004064798A1 (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885802A1 (fr) * 2005-05-17 2006-11-24 Oreal Utilisation cosmetique de la vitamine k pour ameliorer la fonction barriere de la peau
US8003839B2 (en) 2006-02-03 2011-08-23 Exxonmobil Chemical Patents Inc. Process for generating linear apha olefin comonomers
US8076524B2 (en) 2006-02-03 2011-12-13 Exxonmobil Chemical Patents Inc. Process for generating alpha olefin comonomers
US20100130618A1 (en) * 2007-07-24 2010-05-27 Viridis Biopharma Pvt. Ltd. Treatment of human disease conditions and disorders using vitamin k analogues and derivatives
SG11201510680WA (en) * 2013-07-01 2016-01-28 Meiji Co Ltd Method for improving photostability of food and beverage products
US9421297B2 (en) 2014-04-02 2016-08-23 Adhezion Biomedical, Llc Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB744376A (en) 1952-03-08 1956-02-08 Merck & Co Inc Vitamin emulsions
US3070499A (en) * 1960-09-19 1962-12-25 Merck & Co Inc Parenteral aqueous solutions of fat soluble vitamins
JPH05320039A (ja) * 1991-09-20 1993-12-03 Taiyo Kagaku Co Ltd 美白化粧料
DK0643775T3 (da) * 1992-05-28 2004-09-06 Ct For Molecular Biology And M Quinonderivater til forbedring af cellebioenergi
WO1994000135A1 (en) * 1992-06-30 1994-01-06 Shapiro Howard K Composition containing amine and amine-related derivatives of benzoic acid and uses therefor including treating inflammatory diseases
US5510391A (en) * 1993-10-22 1996-04-23 Mayapple Holdings, Llc Method of treating blood vessel disorders of the skin using vitamin K
US5540934A (en) * 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method
WO1997039746A1 (en) 1996-04-22 1997-10-30 Advanced Polymer Systems, Inc. Method of and composition for treating disorders of the skin using vitamin k
US6180136B1 (en) * 1998-11-10 2001-01-30 Idexx Laboratories, Inc. Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use

Also Published As

Publication number Publication date
JP2006515873A (ja) 2006-06-08
CN1738594A (zh) 2006-02-22
HK1087010A1 (en) 2006-10-06
CA2513324C (en) 2010-09-21
ES2314365T3 (es) 2009-03-16
DK1594456T3 (da) 2009-01-19
EP1594456B1 (en) 2008-09-03
DE602004016292D1 (de) 2008-10-16
CA2513324A1 (en) 2004-08-05
EP1594456A1 (en) 2005-11-16
CN100531727C (zh) 2009-08-26
KR20050103906A (ko) 2005-11-01
US20060154983A1 (en) 2006-07-13
ATE406868T1 (de) 2008-09-15
PT1594456E (pt) 2008-12-16
WO2004064798A1 (en) 2004-08-05
US7939568B2 (en) 2011-05-10

Similar Documents

Publication Publication Date Title
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2005032471A3 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
AU2002258066A1 (en) Dermatological and cosmetic compositions
SE0001899D0 (sv) New compounds
WO2004062625A3 (en) Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease
WO2005004803A3 (en) Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005051914A8 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005018545A3 (en) Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
HK1087010A1 (en) Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions
JO2434B1 (en) New retinoids to treat emphysema
PL323364A1 (en) Bicyclic aromatic compounds
AU2108500A (en) Galenic formulation containing biotin
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AU1727797A (en) Heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
EP1178796A4 (en) AMINOIMIDAZOLE CARBOXAMIDE SALTS USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASE
RS11104A (en) Combined preparations,containing 1,4- benzothiepine-1,1- dioxide derivatives and other active substances, and the use thereof
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2002096870A3 (en) Sponge-derived terpenoids and methods of use
ATE439126T1 (de) Antitumorale terpen-verbindungen
HK1050203A1 (en) Novel fusidic acid derivatives.
WO2003014128A3 (de) Tumorhemmende cerverbindungen